3SBio Inc - logo

3SBio Inc - Company & Market Research Reports

3sbio is a biotechnology company that creates biopharmaceutical products. The company was incorporated in 2006, and is headquartered in Shenyang, China. It is a subsidiary of Decade Sunshine Limited. Their products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. 3sbio sell their products to a range of countries including: Brazil, Colombia, Costa Rica ,Dominican Republic, Egypt, El Salvador, Guatemala, Laos, Mongolia, Myanmar, Pakistan, Paraguay, Philippines, Sri Lanka, Thailand and Trinidad and Tobago.


The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition - Product Thumbnail Image

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

  • Report
  • 195 Pages
From
Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics - Product Thumbnail Image

Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

  • Report
  • 43 Pages
From
Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016 - Product Thumbnail Image

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016

  • Report
  • 69 Pages
From
Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016 - Product Thumbnail Image

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016

  • Report
  • 68 Pages
From
Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018 - Product Thumbnail Image

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018

  • Report
  • 116 Pages
From
Renal Anemia - Pipeline Insight, 2018 - Product Thumbnail Image

Renal Anemia - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Renal Anemia - Pipeline Review, H2 2015 - Product Thumbnail Image

Renal Anemia - Pipeline Review, H2 2015

  • Report
  • 124 Pages
From
Renal Anemia - Pipeline Review, H1 2015 - Product Thumbnail Image

Renal Anemia - Pipeline Review, H1 2015

  • Report
  • 121 Pages
From
Competitor Analysis: Cancer Vaccines - Product Thumbnail Image

Competitor Analysis: Cancer Vaccines

  • Report
  • 179 Pages
From
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Inflammatory Skin Diseases Drug Development Pipeline Review, 2018

  • Report
  • 112 Pages
From
Dermatology Therapeutics Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • Report
  • 432 Pages
From
Dermatitis - Pipeline Review, H2 2015 - Product Thumbnail Image

Dermatitis - Pipeline Review, H2 2015

  • Report
  • 445 Pages
From
Hyperphosphatemia - Pipeline Insight, 2018 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Hyperphosphatemia - Pipeline Review, H2 2015 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Review, H2 2015

  • Report
  • 82 Pages
From
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H1 2018 - Product Thumbnail Image

Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H1 2018

  • Report
  • 62 Pages
From
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 244 Pages
From
The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others) - Product Thumbnail Image

The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)

  • Report
  • 195 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
Biopharmaceuticals - Global Strategic Business Report - Product Thumbnail Image

Biopharmaceuticals - Global Strategic Business Report

  • Report
  • 730 Pages
From
Domestic Chinese Biopharmaceutical Companies - Product Thumbnail Image

Domestic Chinese Biopharmaceutical Companies

  • Report
  • 221 Pages
From
Loading Indicator
adroll